These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11055323)

  • 1. Safety and pharmacokinetic study with escalating doses of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy male volunteers.
    Davidson M; Marwah A; Sawchuk RJ; Maki K; Marwah P; Weeks C; Lardy H
    Clin Invest Med; 2000 Oct; 23(5):300-10. PubMed ID: 11055323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C; Labrie F; Archer DF; Ke Y; Gonthier R; Simard JN; Lavoie L; Vaillancourt M; Montesino M; Balser J; Moyneur É;
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J; Couzinet B; Nahoul K; Brailly S; Chanson P; Baulieu EE; Schaison G
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects.
    Legrain S; Massien C; Lahlou N; Roger M; Debuire B; Diquet B; Chatellier G; Azizi M; Faucounau V; Porchet H; Forette F; Baulieu EE
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3208-17. PubMed ID: 10999810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHEA in elderly women and DHEA or testosterone in elderly men.
    Nair KS; Rizza RA; O'Brien P; Dhatariya K; Short KR; Nehra A; Vittone JL; Klee GG; Basu A; Basu R; Cobelli C; Toffolo G; Dalla Man C; Tindall DJ; Melton LJ; Smith GE; Khosla S; Jensen MD
    N Engl J Med; 2006 Oct; 355(16):1647-59. PubMed ID: 17050889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An escalating dose oral gavage study of 3beta-acetoxyandrost-5-ene-7, 17-dione (7-oxo-DHEA-acetate) in rhesus monkeys.
    Henwood SM; Weeks CE; Lardy H
    Biochem Biophys Res Commun; 1999 Jan; 254(1):124-6. PubMed ID: 9920744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Positive effects of DHEA therapy on insulin resistance and lipids in men with angiographically verified coronary heart disease--preliminary study].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):904-10. PubMed ID: 16821209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
    Poretsky L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison MC; Haller I; Rabkin J
    Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men.
    Acacio BD; Stanczyk FZ; Mullin P; Saadat P; Jafarian N; Sokol RZ
    Fertil Steril; 2004 Mar; 81(3):595-604. PubMed ID: 15037408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender.
    Collomp K; Buisson C; Gravisse N; Belgherbi S; Labsy Z; Do MC; Gagey O; Dufay S; Vibarel-Rebot N; Audran M
    Endocrine; 2018 Mar; 59(3):538-546. PubMed ID: 29322301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and hormonal effects of oral DHEA in premenopausal women with HIV infection: a randomized, prospective, placebo-controlled pilot study.
    Poretsky L; Song L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison C; Haller I; Rabkin J
    Horm Metab Res; 2009 Mar; 41(3):244-9. PubMed ID: 18810712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences.
    Bloch M; Meiboom H; Zaig I; Schreiber S; Abramov L
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):910-8. PubMed ID: 23084789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transdermal application of 7-oxo-DHEA on the levels of steroid hormones, gonadotropins and lipids in healthy men.
    Sulcová J; Hill M; Masek Z; Ceska R; Novácek A; Hampl R; Stárka L
    Physiol Res; 2001; 50(1):9-18. PubMed ID: 11300231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed effects of short-term transdermal application of 7-oxo-dehydroepiandrosterone on its metabolites, some hormonal steroids and relevant proteohormones in healthy male volunteers.
    Sulcová J; Hampl R; Hill M; Stárka L; Novácek A
    Clin Chem Lab Med; 2005; 43(2):221-7. PubMed ID: 15843221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
    Coelingh Bennink HJT; Zimmerman Y; Laan E; Termeer HMM; Appels N; Albert A; Fauser BCJM; Thijssen JHH; van Lunsen RHW
    Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
    Ke Y; Labrie F; Gonthier R; Simard JN; Bergeron D; Martel C; Vaillancourt M; Montesino M; Lavoie L; Archer DF; Balser J; Moyneur E;
    J Steroid Biochem Mol Biol; 2015 Nov; 154():186-96. PubMed ID: 26291918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.